Intrinsiqs

Is Corcept Therapeutics Incorporated overvalued?

Corcept Therapeutics Incorporated (CORT) — key valuation metrics and fundamentals.

No verdict
Price
$116.10
Fair value
—
Current P/E
—
Normal P/E
22.3
Market cap
$12.55B
Dividend yield
0.0%
Return on equity
8.4%
Sector
Healthcare

See the full interactive analysis →

Fair value compares CORT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.